The above-mentioned data validated that IL-6 could be an upstream inducer of AKI-related cardiomyocyte damage through upregulation of Grb2, inhibition of Akt/mTOR pathway, and suppression of ATP production. This evidence concerns the gene AKT1 and acute kidney injury.